Aussie-based MGD trial advances towards FDA approval
Australia’s relative success at managing COVID-19 has meant an overseas biotechnology company can forge ahead with the final phase of ...
Australia’s relative success at managing COVID-19 has meant an overseas biotechnology company can forge ahead with the final phase of ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited